Creates the Patient Access to Treatment Act. Provides that
managed care entities may not deny or limit reimbursement to a member
for dermatological services on the grounds that the member was not
referred to the provider by a person acting on behalf of the managed
care entity. Prohibits unreasonable cost-sharing arrangements.
Requires terms and conditions of coverage to be disclosed in a
readable and understandable format consistent with standards developed
for supplemental insurance coverage under the federal Social Security
Act. Effective immediately.
99-02-22 H FIRST READING
99-02-22 H REFERRED TO HOUSE RULES COMMITTEE RULES
99-02-24 H ASSIGNED TO COMMITTEE HEALTH CARE
99-03-05 H RE-REFERRED TO RULES COMM/RULE 19(A) RULES HRUL
01-01-09 H SESSION SINE DIE
END OF INQUIRY
Full Text Bill Summary